Trial Profile
Treatment of mild and subthreshold depressive disorders. A randomized, controlled trial on the efficacy of a serotonin-reuptake-inhibitor (SSRI), a cognitive-behavioral therapy and of free choice between SSRI and CBT
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Depression; Depressive disorders
- Focus Therapeutic Use
- 01 Feb 2010 Results published in the International Journal of Neuropsychopharmacology.
- 17 Nov 2005 New trial record.